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INTRODUCTION

ABSTRACT:
INTRODUCTION:Telemedicine
can
address
healthcare
disparities by improving access to care and eliminating barriers
to in-office appointments. The primary goal of this study is to
compare the number of completed telemedicine appointments
to the number of completed in-office appointments for an
OBGYN residency clinic during the early months of the COVID
pandemic. The study also aims to evaluate patient demographics
and types of visits performed using telemedicine.
METHODS: All OBGYN residency clinic visits at a single institution
from March 2020 – May 2020 were included and reviewed.
Proportions of the visit type were evaluated for completion as
well as the inability to complete the appointment through the
telemedicine format. Information collected for the telemedicine
visits includes the patient age, primary language spoken, and
use of an interpreter during the visit. For patients who were a
“no show” to a telemedicine appointment, appointments were
reviewed to assess if the patient rescheduled or was lost to
follow up. Overall appointment completion rates were compared
between telemedicine and in-office visits using a Chi-squared test.
RESULTS: Between March - May 2020, there were 598
telemedicine visits at the residency clinic, with 479 (80.1%)
completed and 119 (19.9%) not completed. By comparison,
in-office visits totaled 3,158 visits, with 78% (2,473) completed
and 22% (685) not completed. Chi-squared test comparing
telemedicine versus in office visits resulted in a non-significant
p-value of 0.32.
CONCLUSION:The overall visit completion rate between
telemedicine and in-office visits from March - May 2020 was
similar. The p-value comparing the completion rates was nonsignificant at 0.32, suggesting the telemedicine visit completion
rate is comparable to in-office appointment completion rate.
KEYWORDS: telemedicine, residency clinic, obstetrics and
gynecology
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T

he World Health Organization declared coronavirus infectious disease, 2019 (COVID-19) a global
pandemic in March of 2020.1 The pandemic presented an unprecedented challenge for healthcare, prompting the implementation of telemedicine in attempts to
control the spread of the virus.1 Telemedicine was most readily implemented in the
ambulatory care setting.1 Telemedicine
served to minimize exposure between patients in waiting areas and protected the
physician work force from exposures in
patient encounters.1
Telemedicine is an established method of
patient interaction in the field of medicine.
Modern telemedicine was first employed
by Massachusetts General Hospital in
1968, with the use of remote examinations to people traveling and working at
the Logan International Airport.2 The use
of telemedicine has developed over time
and has a role in both inpatient and outpatient settings. Telemedicine allows for
better monitoring of patients in intensive
care units, allows for increased surveillance of certain disease processes, and
provides access to specialty and subspecialty services that may not otherwise be
available.3 Telemedicine can improve access to care, decrease cost of care (directly or through reducing role functioning
losses), and to improve quality of care by
allowing the patient access to the appropriate provider.3 The use of telemedicine
in the ambulatory setting reduces the
distance patients need to travel for care
and can help eliminate care disparities in
rural or underserved settings.2,3
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There are a limited number of randomized controlled
trials which address clinical outcomes with telemedicine. Theoretically, patient outcomes should
be no different as that of in-person care if standard
of care is followed in the telemedicine encounter.3
Prior research also indicates overwhelming patient
satisfaction with telemedicine appointments due to
increased communication, decreased wait time, ease
of use and patient empowerment.3 The main limitation of telemedicine is the inability to perform a
hands-on physical examination of the patient.3
Telemedicine has applications in the field of obstetrics and gynecology (OBGYN). For example, prenatal genetic counseling can be done through videoconferencing, allowing illustration of diagrams and
pictures for patient education.4 Ultrasound can be
performed in real-time with a consultant viewing the
images and counseling the patient simultaneously.4
Other visits suited for telemedicine include preconception counseling, reviewing results and medication follow up. Interpreting services can be linked to
the visit as well.4 Management of comorbid conditions such as diabetes and hypertension, as well as
review of non-stress tests can be performed via telemedicine.4 Telemedicine can also be used to improve
patient access to obstetrical counseling and extended
subspecialty services not offered at many locations.4
There is little published research in the field of
OBGYN regarding telemedicine, and even less
regarding the use of telemedicine in an OBGYN
residency program. This project aims to assess the
effectiveness of telemedicine visits in an OBGYN
residency clinic by evaluating completion/show rate
for telemedicine appointments as compared to in-office appointments. Telemedicine visits will be more
specifically analyzed to review patient demographics
as well as type of problem addressed during telemedicine visits. The hypothesis for this study is that telemedicine is an effective alternative to in-office visits
for appropriately selected patient visits, with anticipated improved visit completion. Given that residency clinics often serve the underserved and marginalized communities, the expansion and integration of
telemedicine in residency training has the potential
to reach underserved communities and improve the
overall health of women in our community.
MATERIALS AND METHODS
This is a retrospective cohort study. All visits performed by residents, attending physicians and advanced practice providers in an OBGYN resident
clinic during March 2020 – May 2020 were reviewed. Prior to this time period, telemedicine had
© Tower Health
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not been used in the resident clinic. Patients were
deemed to be appropriate for a telemedicine appointment after the scheduled office visit and chief complaint were reviewed by the most-senior resident in
clinic and identified patients whose complaints were
unlikely to require physical examination. Telemedicine appointments were evaluated for type of visit,
completion rate, as well as the need for the patient
to present for an in-person visit due to inability to
complete the appointment virtually. Demographic information collected for the telemedicine visits
included patient age and primary language spoken.
Additional information included use of an interpreter during the telemedicine visit. For patients
who were marked as “no show” to a telemedicine
appointment, appointments were reviewed to assess
if the patient rescheduled their appointment or was
lost to follow up for that encounter. Overall telemedicine appointment completion rate was compared to
in-office clinic visit completion rate over the same
timeframe using a Chi-square test.5 Sample size calculation was not performed as the number of clinic
visits in the mentioned time frame is fixed.
RESULTS
The total number of telemedicine visits between
March - May 2020 completed at the OBGYN residency clinic was 598 visits. Of these visits, 479
(80.1%) were completed and 119 (19.9%) were not
completed. Table 1 summarizes the total number of
patients for each visit type. The mean age for patients was 30.75 years, with a median of 28 years
and a range of ages 11 to 90 years.
The most common telemedicine visit type was a
gynecology (GYN) visit with 334 appointments
(55.9%), followed by obstetric (OB) visits at 141
appointments (23.6%), then postpartum at 73 appointments (12.2%) and results follow-up at 50
appointments (8.4%). There were 151 Spanish
speaking patients (25.3%), with Spanish being the
only non-English language used by patients in this
cohort. An interpreter was documented as being
used for 102 of these encounters (67.5% of Spanish speaking patients). Only 16 (2.7%) of all telemedicine appointments resulted in the patient being
asked to present for same-day in-person evaluation.
Of these 16 visits, 10 were GYN and the remaining
6 were OB visits (Table 2).
117 appointments of the total 119 not completed/ “no
show” telemedicine appointments were successfully
re-scheduled. Of these re-scheduled appointments,
only 27 did not show for the re-scheduled visit (Table 3).
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In comparison, the total number of in-office visits
for residents, attending physicians and advanced
practice providers during this time frame was
5,050 – this total number did not include nursing
or medication administration visits. The total number of completed visits was 2,473 (49%). A total of
1,892 visits (37.5%) were cancelled, either by the
patient or by office staff. Reason for cancellation
was not documented for these visits. The number of
not-completed visits was 685 (13.6%). As cancelled
visits were not tracked in the telemedicine data review, removing these visits from the in-office total
results in a total of 3,158 visits, with 78% completed
and 22% not completed (Table 4). Chi-squared analysis performed comparing the overall completion
rate between telemedicine and in-office appointments during this time frame (Table 5), resulted in a
non-significant p-value of 0.32.
DISCUSSION
The overall visit completion rate between telemedicine and in office visits from March - May 2020 was
similar, as demonstrated by an 80.1% completion
rate for telemedicine and a 78% completion rate for
in-office visits. The p-value comparing the completion rates was non-significant at 0.32, suggesting the
telemedicine visit completion rate is comparable to
in-office appointment completion rate. Only 2.7% of
telemedicine visits resulted in a patient being called
in for an in-office appointment the same day. Appropriately selecting patient visit types for telemedicine
appointments resulted in a high percentage completed virtually. Additionally, nearly all patients whose
telemedicine visit was not completed initially were
re-scheduled (98.3%) to either an in-office or telemedicine appointment (Table 3). If these re-scheduled visits are counted in the completed total, only
27 (4.5%) of the 598 telemedicine patients ultimately were lost to follow up care.
Interpreter use for Spanish speaking patients was
documented for 102 of 151 encounters. One advanced practice provider who provided care during
this time frame did not use interpreters for her encounters as she is fluent in Spanish and preferred
to carry out these visits without the use of interpretation services. For the encounters that did use an
interpreter, no difficulties were documented regarding need to call for multiple interpreters during an
encounter or having to change midway through a
conversation due to technical difficulties.
A limitation of this study includes inconsistent
tracking between telemedicine and in-office visits
with regards to cancellations. Cancelled visits were
© Tower Health

Table 1: Telemedicine Appointment Visit Type
Visit Type

Total Number
of Patients

Overall
Percentage

Gynecology

334

55.9%

Obstetric

141

23.6%

Postpartum

73

12.2%

Results

50

8.4%

598

100%

Total

Table 2: Outcome of Rescheduled
Not-Completed Telemedicine Visits
Appointment
Outcome

Number of
Patients

Overall
Percentage

No show to
rescheduled
appointment

27

23.1%

In office GYN

41

35%

In office OB

22

18.8%

Telemedicine

20

17.1%

Postpartum

4

3.4%

Transferred care

3

2.6%

117

100%

Total

Table 3: In-Office Appointment
Completion Rate
Appointment
Completion
Completed
No Show
Total

Number
of Patients

Overall
Percentage

2,473

78%

685

22%

3,158

100%

not included in the telemedicine data review totals.
Also, the information assessed in depth for the telemedicine visits such as encounter type and patient
demographics were not reviewed for in-office appointments in the same time frame, limiting overall
ability for comparison of the visit types. Additionally, patient satisfaction was not assessed with this
project, which may be an avenue of further study.
Finally, revenue and cost relating to telemedicine
appointments were not assessed.
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Table 5: Chi-square Analysis of Telemedicine and In-Office Visit Completion5
Completed Visit
Chi-squared statistic

No Show Visit
Chi-squared statistic

Telemedicine

0.17

0.63

In-Office

0.03

0.12

CONCLUSION

Visit Chi-squared
statistic

P value

0.96

0.32

REFERENCES

Telemedicine is likely to become a more widely offered service given social distancing practices with
the advent of COVID-19. It is important to evaluate the effectiveness of telemedicine encounters and
generate thoughts on improvement moving forward
for revenue generation and enhancement of patient
access to care. This study shows that telemedicine
encounters are similar in terms of completion to
in-office appointments, and with appropriately selected visit types have a low likelihood of a patient
being brought in for evaluation. Telemedicine allows for comparable visit completion rates, as well
as a new avenue for resident education.

1. H
 incapié MA, Gallego JC, Gempeler A, Piñeros JA, Nasner D, Escobar MF.
Implementation and usefulness of telemedicine during the covid-19 pandemic: a
scoping review. J Prim Care Community Health. 2020;11:215013272098061.
https://doi.org/10.1177/2150132720980612
2 . Weinstein RS, Krupinski EA, Doarn CR. Clinical Examination Component of
Telemedicine, Telehealth, mHealth, and Connected Health Medical Practices.
Medical Clinics of North America. 2018;102(3):533-544.
https://doi.org/10.1016/j.mcna.2018.01.002
3. Waller M, Stotler C. Telemedicine: a Primer. Curr Allergy Asthma Rep.
2018;18(10):54. https://doi.org/10.1007/s11882-018-0808-4
4. M
 agann EF, McKelvey SS, Hitt WC, Smith MV, Azam GA, Lowery CL.
The use of telemedicine in obstetrics: a review of the literature. Obstetrical &
Gynecological Survey. 2011;66(3):170-178.
https://doi.org/10.1097/OGX.0b013e3182219902
5. Social Science Statistics. Chi Square Test Calculator. Social Science Statistics

© Tower Health

https://scholarcommons.towerhealth.org/t-med/vol1/iss3/3
DOI: https://doi.org/10.54299/tmed/jhpl5159

Transform Med | Vol 1, No 3. September 2022 | https://doi.org/10.54299/tmed/jhpl5159

56

